1.Multiple metallic stents placement for malignant hilar biliary obstruction: Perspective of a radiologist.
Yozo SATO ; Yoshitaka INABA ; Kazuo HARA ; Hidekazu YAMAURA ; Mina KATO ; Shinichi MURATA ; Yui ONODA
Gastrointestinal Intervention 2016;5(1):52-59
In the palliative setting, the necessity of biliary drainage of both liver lobes for malignant hilar biliary obstruction remains controversial. However, bilateral biliary drainage is a reasonable option to prevent cholangitis of the undrained lobe and to preserve liver function during the course of chemotherapy. Bilateral biliary drainage can be accomplished by the percutaneous or endoscopic placement of multiple self-expandable metallic stents (SEMS). Although SEMS placement via bilateral (multiple) percutaneous routes is technically simple, multiple percutaneous transhepatic biliary drainage (PTBD) may lead to additional morbidity. SEMS placement via a single percutaneous route is a useful method; however, negotiation of a guidewire into the contralateral bile duct is occasionally impossible if the hilar angle between the right hepatic duct and left hepatic duct is acute. Percutaneous dual SEMS placement is generally performed using the stent-in-stent technique (T configuration or Y configuration) or the side-by-side technique. In addition, the crisscross technique has been reported as being a useful method for trisegmental drainage. The side-to-end technique is also useful for multiple SEMS placement. In the future, the combination of percutaneous intervention and endoscopic ultrasonography-guided procedures may be effective in the management of malignant hilar biliary obstruction.
Bile Ducts
;
Biliary Tract Neoplasms
;
Cholangitis
;
Drainage
;
Drug Therapy
;
Hepatic Duct, Common
;
Liver
;
Methods
;
Negotiating
;
Stents*
2.Degradable Gelatin Microspheres as an Embolic Agent: an Experimental Study in a Rabbit Renal Model.
Shinichi OHTA ; Norihisa NITTA ; Masashi TAKAHASHI ; Kiyoshi MURATA ; Yasuhiko TABATA
Korean Journal of Radiology 2007;8(5):418-428
OBJECTIVE: To investigate the basic characteristics of degradable gelatin microspheres (GMSs), including their embolic behavior and degradation periods when they are used as embolic materials in the renal arteries of rabbit models. MATERIALS AND METHODS: Based on the GMS particle size, 24 kidneys were divided into 3 groups of eight kidneys, and each group was embolized with a different GMS particle size (group 1: 35-100 micrometer, group 2: 100-200 micrometer, and group 3: 200-300 micrometer). From each group, two rabbits were sacrificed immediately after embolization (day 0), and a pair of rabbits from each group underwent an angiogram and were sacrificed on days 3, 7, and 14, respectively, after embolization. The level of arterial occlusion, the pathological changes in the renal parenchyma, and the degradation of the GMSs were evaluated angiographically and histologically. RESULTS: A follow-up angiogram on days 0, 3, 7, and 14 revealed the presence of wedge-shaped poorly-enhanced areas in the parenchymal phase as seen in all groups. The size of these areas tended to increase with the particle diameter, and persisted up to day 14. On days 3, 7, and 14, parenchymal infarctions were observed histologically in all cases, and this observation corresponded with the parenchyma being supplied by the embolized arteries. GMSs of group 1 mainly reached the interlobular arteries, while those of group 3 mainly reached the interlobar arteries. In all but two cases, the GMSs were identified histologically even on day 14, and sequential degradation was histologically identified in all GMS groups. CONCLUSION: GMSs can be used as degradable embolic materials which can control the level of embolization.
Animals
;
Biocompatible Materials
;
Disease Models, Animal
;
Embolization, Therapeutic/*methods
;
Female
;
Follow-Up Studies
;
*Gelatin
;
Kidney/blood supply
;
*Microspheres
;
Particle Size
;
Rabbits
;
Renal Artery/drug effects/pathology/radiography
;
Renal Artery Obstruction/*chemically induced
;
Severity of Illness Index
;
Time Factors
3.Neurolytic Caudal Epidural Block for Rectal Tenesmus: A Case Report
Naohisa MATSUMOTO ; Tomoe FUKUNAGA ; Kazue MONMA ; Yuya MURATA ; Daisuke OKABE ; Shinichi ISHIKAWA
Palliative Care Research 2023;18(2):137-141
Rectal tenesmus is a very uncomfortable symptom. Though antiarrhythmic drugs and nerve blocks have been proposed as a treatment for rectal tenesmus, none is well-established. We report a 68-year-old female who undertook surgery for uterine cervical cancer and underwent chemotherapy. She got a bilateral nephrostomy and bowel obstruction during the chemotherapy because of recurrence. She decided to stop chemotherapy and to receive palliative care. She had a symptom of rectal tenesmus, which was refractory to medications. The clinical sign was severe and uncomfortable, making her very nervous. We planned to treat the rectal tenesmus with a nerve block. A ganglion impar block was insufficient to remove the symptom, and the saddle block failed due to epidural lipomatosis. We finally succeeded in alleviating the sign with a neurolytic caudal epidural block. Relief of tenesmus made her hope to spend her final period at home. She could stay at home with her family for seven days before death without recurrence of the symptom. Though there is no report about the effectiveness of neurolytic caudal epidural block for rectal tenesmus, we consider the block appropriate for the symptom.